This FAQ complements the WHO interim guidance. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected.
The interim guidance and FAQ reflect: i. the available evidence regarding transmission risks of COVID-19 through breastmilk; ii. the protective effects of breastfeeding and skin-to-skin contact, and, iii. the harmful effects of inappropriate use of infant formula milk.